We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation plant that strengthens our biocatalysis capabilities. This expansion increases our total enzyme fermentation capacity to 22,850 L, allowing us to better meet your project’s unique needs by offering greater scalability, speed, and efficiency.
WuXi STA’s Biocatalysis Technology Platform provides comprehensive solutions, from enzyme screening, enzyme evolution and enzyme production to biocatalytic process development and production. With over 2,500 library enzymes and expertise in 25+ reaction types, we’re here to ensure your projects move forward with confidence and success. In 2023, we applied biocatalysis across 60 synthetic steps, producing over 90 metric tons of APIs and intermediates, helping our partners bring treatments to market faster and more sustainably.
